Altered fibrin clot properties in patients with retinal vein occlusion

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 12, 2011, Pages 2513-2515

  Karska Basta, I ^a   Kubicka TrzaSka, A ^a   Romanowska Dixon, B ^a   Undas, A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ATHEROSCLEROSIS; FEMALE; FIBRIN CLOT; FIBRINOLYSIS; HUMAN; HYPERTENSION; LETTER; MALE; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RISK ASSESSMENT;

C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; FEMALE; FENOFIBRATE; FIBRIN; FIBRINOLYSIS; HEPTANOIC ACIDS; HOMOCYSTEINE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LASER COAGULATION; LIPOPROTEIN(A); MALE; PYRROLES; RETINAL VEIN; RETINAL VEIN OCCLUSION; SIMVASTATIN; TETRAHYDROISOQUINOLINES; THROMBOSIS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 82755189876     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04522.x     Document Type: Letter

References (11)

1. Collet JP, Allali Y, Lesty C, Tanguy ML, Silvain J, Ankri A, Blanchet B, Dumaine R, Gianetti J, Payot L, Weisel JW, Montalescot G. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 2006; 26: 2567-73.
2. Undas A, Podolec P, Zawilska K, Pieculewicz M, Jedlinski I, Stepien E, Konarska-Kuszewska E, We{ogonek}glarz P, Duszyńska M, Hanschke E, Przewlocki T, Tracz W. Altered fibrin clot structure/function as a novel risk factor for cryptogenic ischemic stroke. Stroke 2009; 40: 1499-501.
3. Undas A, Zawilska K, Ciesla-Dul M, Lehmann-Kopydlowska A, Skubiszak A, Cieplłuch K, Tracz W. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. Blood 2009; 114: 4272-8.
4. Rogers S, McIntosh R, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2009; 117: 313-9.
5. Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 2010; 8: 1886-94.
6. Undas A, Cieśla-Dul M, Dra{ogonek}żkiewicz T, Potaczek DP, Sadowski J. Association between atopic diseases and venous thromboembolism: a case-control study in patients aged 45years or less. J Thromb Haemost 2011; 9: 870-3.
7. Za{ogonek}bczyk M, Glłowacki R, Machnik A, Heród P, Kazek G, Jakubowski H, Undas A. Elevated concentrations of Ne{open}-homocysteinyl-lysine isopeptide in acute myocardial infarction: links with ADMA formation. Clin Chem Lab Med 2011; 49: 729-35.
8. Undas A, Plicner D, Ste{ogonek}pień E, Drwila R, Sadowski J. Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C-reactive protein, lipoprotein(a) and homocysteine. J Thromb Haemost 2007; 5: 1988-90.
9. Undas A, Celinska-Lowenhoff M, Lowenhoff T, Szczeklik A. Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost 2006; 4: 1029-36.
10. Salonen EM, Vartio T, Hedman K, Vaheri A. Binding of fibronectin by the acute phase C- reactive protein. J Biol Chem 1984; 259: 1496-501.
11. Sofi F, Mannini L, Marcucci R, Bolli P, Sodi A, Giambene B, Menchini U, Gensini GF, Abbate R, Prisco D. Role of haemorheological factors in patients with retinal vein occlusion. Thromb Haemost 2007; 98: 1215-9.